Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 13, 2026Annals of HematologyOpen Access

NGS and emerging molecular scenarios in chronic myeloproliferative neoplasms: a case of double mutated polycythemia vera

View Full Paper
Ask AI
Bookmark
Share

Authors

ECElisabetta CerchiaraACAntonio CristianoFVFederico Vozella

Discussion

Loading...

Member takes

Overview

Randomized trial shows altered disease phenotype in myeloproliferative neoplasms, indicating the importance of comprehensive genetic testing.

Key Points

  • To investigate the presence of double mutations in polycythemia vera and their impact on disease evolution and diagnosis.
  • Performed NGS analysis on a 71-year-old man with JAK2-positive polycythemia vera.
  • Conducted a retrospective analysis of clonal dynamics and histopathological evaluation.
  • Assessed hematologic parameters under hydroxycarbamide treatment for disease progression.
  • NGS revealed CALR mutation alongside non-driver DNMT3A variants, with low VAF JAK2 clone below detection limit.
  • Dynamic clonal competition was observed between dominant CALR clone and minor JAK2 clone.
  • Histopathological findings consistent with polycythemia vera confirmed the integrated diagnosis of MPN-NOS.

Cite This Study

Cerchiara et al. (2026) studied this question.

synapsesocial.com/papers/6a2cf36efaef96ed7f055f9dhttps://doi.org/10.1007/s00277-026-07099-6
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1MPN with multiple driver clones show distinct patterns of therapy response and progression - “MPN double driver”2025 · 2 citations
  2. 2PO51 | Thrombocythemia associated with a non-canonical JAK2 mutation: a case report2025
  3. 3Genetic evolution of myeloproliferative neoplasms from chronic phase to blastic phase: An analysis of 46 paired samples.2025 · 6 citations
  4. 4Clinical features and outcomes of myeloproliferative neoplasm patients with MPL mutations and concurrent JAK2/calr mutations2025
  5. 5Longitudinal genomic shifts associated with disease transformation in patients with polycythemia vera (PV) enrolled in REVEAL2025